CryoLife seeks Australian/Canadian approval:
This article was originally published in Clinica
Executive Summary
CryoLife is seeking approval in Australia and Canada for its BioGlue surgical adhesive to be used as a vascular and pulmonary sealant. In Australia, the approval process could take up to nine months. However, while it is under review, the Australian Therapeutic Goods Administration has agreed to allow doctors to use the adhesive if they apply for an individual patient use. The Atlanta, Georgia-based company already markets the product in Europe for vascular surgical procedures and pulmonary applications.